Europe needs to make some very big technology bets — with EU financed venture capital money

Synthetic biology is one area that may merit large-scale investment in benign applications




Journalist, policy analyst, eco-warrior.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Advice for better startup accelerator selection panels

Why Valuations are Pointless and How VC Supermoney is Driving Inequality

Why We Invested in SentiLink

Good investor / Bad investor

Tokyo Imperial Palace

Sequoia’s First Woman Partner Is Raising Capital, and Standards

Investors to Avoid for your First Fundraise.

The Venture Capitalists Making a Bet on Aging Consumers

The Great Unbundling of Venture Capital 2021: Emerging Trends, Challenges and Opportunities

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Jasper Sky

Jasper Sky

Journalist, policy analyst, eco-warrior.

More from Medium

The Business of Bikaji Foods

Burn Rate — Chapter 9

How Business Agility Increases Revenue

Cellular Agriculture Needs B2B Businesses. Build Them With Us.